New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Passage Bio, Inc. (PASG) vs Quantum Biopharma Ltd. (QNTM)
- Passage Bio, Inc. PASG 3.92 +8.59%
- Quantum Biopharma Ltd. QNTM 1.29 −9.15%
Passage Bio, Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. Passage Bio, Inc. and Quantum Biopharma Ltd. are of similar size ($12.6M and $11.6M). Across the 9 metrics below, Quantum Biopharma Ltd. leads on 6 and Passage Bio, Inc. on 3.
Valuation
Profitability
| Metric | PASG | QNTM | Biotechnology median |
|---|---|---|---|
| Gross margin | — | (1,068.29%) | 70.18% |
| Operating margin | — | (9,699.83%) | 0.00% |
| Net margin | — | (16,880.72%) | 0.00% |
| Free cash flow margin | — | (6,089.39%) | 0.00% |
| Return on equity | (212.27%) | (233.09%) | (51.58%) |
| Return on assets | (69.68%) | (127.92%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack